Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-02-27 @ 12:49 AM
Study NCT ID:
NCT04956302
Status:
TERMINATED
Last Update Posted:
2024-06-06
First Post:
2021-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Sponsor:
Abdullah Khan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-30
First Submit QC Date:
None
Study First Post Date:
2021-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-04
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL